This collection
is approved through 2/01. FDA will develop and submit the final
rule during this time, in time for the final version of the
guidance to go into effect before the expiration of the collection
that has been approved here.
Inventory as of this Action
Requested
Previously Approved
03/31/2001
03/31/2001
05/31/2000
11,913
0
11,913
641,705
0
641,705
0
0
0
Guidance to assist applicants in
reporting to FDA changes to an approved NDA or ANDA.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.